The SRIT India IPO is a closed mainboard Bookbuilding offer (Fresh capital only) that opened on 28 September 2026. The SRIT India IPO closed on 30 September 2026, with an issue price of ₹130 per share. The SRIT India IPO has a face value of ₹5 and a lot size of 115 shares. The SRIT India IPO size aggregates up to ₹218 crore, listing on NSE & BSE on 6 October 2026. The SRIT India IPO allotment was scheduled for 1 October 2026.
On the financial front, the SRIT India IPO reported revenue of ₹463 crore for 31 Mar 2026, compared with ₹401 crore for 31 Mar 2025. The SRIT India IPO PAT was ₹43 crore against ₹34 crore. The SRIT India IPO EBITDA stood at ₹65 crore with a 14.39% margin. The SRIT India IPO net worth as of 31 Mar 2026 was ₹193 crore.
Always verify The SRIT India IPO details and GMP data with the official offer document before investing in the SRIT India IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
614
497
429
Revenue
463
401
282
PAT
43
34
29
EBITDA
65
50
41
Net Worth
193
93
80
Reserves
170
73
54
Total Borrowing
36
51
22
SRIT India IPO Financials FAQs
Revenue of SRIT India (Amount in ₹ Crore) — 31 Mar 2026: 463; 31 Mar 2025: 401; 31 Mar 2024: 282. Profit after tax (PAT) — 31 Mar 2026: 43; 31 Mar 2025: 34; 31 Mar 2024: 29.
EBITDA of SRIT India (Amount in ₹ Crore) — 31 Mar 2026: 65; 31 Mar 2025: 50; 31 Mar 2024: 41. The EBITDA margin is 14.39%.
Total assets — 31 Mar 2026: 614; 31 Mar 2025: 497; 31 Mar 2024: 429. Net worth — 31 Mar 2026: 193; 31 Mar 2025: 93; 31 Mar 2024: 80. Reserves & surplus — 31 Mar 2026: 170; 31 Mar 2025: 73; 31 Mar 2024: 54. (Amount in ₹ Crore)
Total borrowing of SRIT India (Amount in ₹ Crore) — 31 Mar 2026: 36; 31 Mar 2025: 51; 31 Mar 2024: 22. Debt-to-equity ratio: 0.23.
The financials shown for SRIT India IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.